Neuroglia in neurodegeneration
暂无分享,去创建一个
Michael T. Heneka | Alexei Verkhratsky | A. Verkhratsky | Jose Julio Rodriguez | M. Heneka | José J. Rodríguez
[1] M. Mena,et al. Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[2] S. Oliet,et al. Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine , 2009, Neuroscience.
[3] J. Hell,et al. Thrombospondins Are Astrocyte-Secreted Proteins that Promote CNS Synaptogenesis , 2005, Cell.
[4] Mark Ellisman,et al. Protoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains , 2002, The Journal of Neuroscience.
[5] A. Verkhratsky,et al. Neuronal-glial networks as substrate for CNS integration , 2006, Journal of cellular and molecular medicine.
[6] G. Levi,et al. Up‐regulation of Cyclooxygenase‐2 Expression in Cultured Microglia by Prostaglandin E2, Cyclic AMP and Non‐steroidal Anti‐inflammatory Drugs , 1997, The European journal of neuroscience.
[7] B. MacVicar,et al. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions , 2004, Nature.
[8] T. Klockgether,et al. Neuronal and Glial Coexpression of Argininosuccinate Synthetase and Inducible Nitric Oxide Synthase in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[9] Serge Charpak,et al. GABA, a forgotten gliotransmitter , 2008, Progress in Neurobiology.
[10] J. Coyle,et al. Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.
[11] T. Takano,et al. Astrocyte-mediated control of cerebral blood flow , 2006, Nature Neuroscience.
[12] G. Rosoklija,et al. Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis , 2001, Annals of neurology.
[13] P. Mcgeer,et al. The possible role of complement activation in Alzheimer disease. , 2002, Trends in molecular medicine.
[14] M. Sawada,et al. Inflammatory process in Parkinson's disease: role for cytokines. , 2005, Current pharmaceutical design.
[15] M. Simard,et al. The neurobiology of glia in the context of water and ion homeostasis , 2004, Neuroscience.
[16] S. Amor,et al. Preactive lesions in multiple sclerosis , 2009, Current opinion in neurology.
[17] Masahiko Watanabe,et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. , 1997, Science.
[18] A. Floden,et al. β-Amyloid Stimulates Murine Postnatal and Adult Microglia Cultures in a Unique Manner , 2006, The Journal of Neuroscience.
[19] E. Newman,et al. Potassium buffering in the central nervous system , 2004, Neuroscience.
[20] G. Struhl,et al. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.
[21] G. Cole,et al. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain , 2004, Neurobiology of Aging.
[22] A. Cornell-Bell,et al. Human epileptic astrocytes exhibit increased gap junction coupling , 1995, Glia.
[23] Eric A Newman,et al. Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling , 2006, The Journal of Neuroscience.
[24] M. Berry,et al. Cytology and lineage of NG2-positive glia , 2002, Journal of neurocytology.
[25] V. Gallo,et al. NG2‐positive cells in the mouse white and grey matter display distinct physiological properties , 2004, The Journal of physiology.
[26] J. Ojemann,et al. Uniquely Hominid Features of Adult Human Astrocytes , 2009, The Journal of Neuroscience.
[27] D. Bergles,et al. Physiological characteristics of NG2-expressing glial cells , 2002, Journal of neurocytology.
[28] Christian Steinhäuser,et al. Astrocytic function and its alteration in the epileptic brain , 2008, Epilepsia.
[29] Tony Wyss-Coray,et al. Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.
[30] Kenneth J. Smith,et al. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding , 2001, Current opinion in neurology.
[31] D. Gutmann,et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.
[32] Jm Charcot,et al. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .
[33] I. Blumenthal,et al. Periventricular leucomalacia: a review , 2004, European Journal of Pediatrics.
[34] Ted M. Dawson,et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.
[35] C. Schleich. Schmerzlose Operationen: Örtliche Betäubung mit indifferenten Flüssigkeiten. Psychophysik des natürlichen und künstlichen Schlafes , 1906 .
[36] James Parkinson,et al. An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[37] D. Spencer,et al. Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[39] Michael T. Heneka,et al. Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.
[40] Stephen J. Smith,et al. Neuronal activity triggers calcium waves in hippocampal astrocyte networks , 1992, Neuron.
[41] C. Ferrari,et al. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease , 2008, Brain : a journal of neurology.
[42] Alexei Verkhratsky,et al. Neuroglia: the 150 years after , 2008, Trends in Neurosciences.
[43] C. Heyser,et al. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] A. Pramatarova,et al. Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment , 2001, The Journal of Neuroscience.
[45] P. Haydon,et al. Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Kollias,et al. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.
[47] D. Spray,et al. Connexin43 null mice reveal that astrocytes express multiple connexins , 2000, Brain Research Reviews.
[48] R. Leech,et al. Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. , 2005, Clinical neuropathology.
[49] B. Roth,et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.
[50] Q. Wang,et al. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis , 2004, Annals of neurology.
[51] D. Middleton,et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia: a case-control study , 2001, The Lancet.
[52] Santiago Canals,et al. The role of astroglia on the survival of dopamine neurons , 2002, Molecular Neurobiology.
[53] M. Norenberg,et al. Glutamine synthetase: glial localization in brain , 1977, Science.
[54] M. Ato,et al. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ , 2001, Journal of Neuroimmunology.
[55] D. Dickson,et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.
[56] J. Kershman. GENESIS OF MICROGLIA IN THE HUMAN BRAIN , 1939 .
[57] Jose Julio Rodriguez,et al. Astroglia in dementia and Alzheimer's disease , 2009, Cell Death and Differentiation.
[58] Michael M. Halassa,et al. The tripartite synapse: roles for gliotransmission in health and disease. , 2007, Trends in molecular medicine.
[59] S. Barger,et al. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E , 1997, Nature.
[60] M. D. de Bellard,et al. Glial cells: old cells with new twists. , 2008, Acta histochemica.
[61] S. Roßner,et al. Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme , 2005 .
[62] K. Nave,et al. NG2‐expressing cells in the nervous system revealed by the NG2‐EYFP‐knockin mouse , 2008, Genesis.
[63] M. Mena,et al. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity , 1999, Journal of Neural Transmission.
[64] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[65] Jialin C. Zheng,et al. Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia , 2009, Neurotoxicity Research.
[66] C. Matute. P2X7 Receptors in Oligodendrocytes: A Novel Target for Neuroprotection , 2008, Molecular Neurobiology.
[67] C. B. Kunst,et al. Complex genetics of amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[68] R. Jabs,et al. Lack of P2X receptor mediated currents in astrocytes and GluR type glial cells of the hippocampal CA1 region , 2007, Glia.
[69] S. Przedborski,et al. Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.
[70] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[71] T. Montine,et al. Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.
[72] A. Araque,et al. Tripartite synapses: glia, the unacknowledged partner , 1999, Trends in Neurosciences.
[73] S. Gobbo,et al. Astrocytic Glutamate Is Not Necessary for the Generation of Epileptiform Neuronal Activity in Hippocampal Slices , 2006, The Journal of Neuroscience.
[74] G. Landreth,et al. β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis , 2001, The Journal of Neuroscience.
[75] H. Kettenmann,et al. Membrane currents and cytoplasmic sodium transients generated by glutamate transport in Bergmann glial cells , 2007, Pflügers Archiv - European Journal of Physiology.
[76] M. Schwartz,et al. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective , 2005, Molecular and Cellular Neuroscience.
[77] J. Langeveld,et al. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q , 2005, Neurobiology of Disease.
[78] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[79] L. Schweitzer,et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. , 1997, Journal of immunology.
[80] Pierre J Magistretti,et al. Role of glutamate in neuron-glia metabolic coupling. , 2009, The American journal of clinical nutrition.
[81] B. Hyman,et al. Immunohistochemical Study of the β-Chemokine Receptors CCR3 and CCR5 and Their Ligands in Normal and Alzheimer's Disease Brains , 1998 .
[82] M. D'Andrea,et al. Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains , 2003, Brain Research.
[83] P. Mcgeer,et al. Inflammatory processes in amyotrophic lateral sclerosis , 2002, Muscle & nerve.
[84] V. Bigl,et al. Astrocytic expression of the Alzheimer's disease β‐secretase (BACE1) is stimulus‐dependent , 2003, Glia.
[85] A. Kölliker. Handbuch der Gewebelehre des Menschen : für Aerzte und Studirende , 1863 .
[86] C. Sherrington,et al. On the Regulation of the Blood‐supply of the Brain , 1890, The Journal of physiology.
[87] M. Kavanaugh,et al. Flux coupling in a neuronal glutamate transporter , 1996, Nature.
[88] A. Nishiyama,et al. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity , 2009, Nature Reviews Neuroscience.
[89] Pierre J Magistretti,et al. Neuron-glia metabolic coupling and plasticity. , 2006, The Journal of experimental biology.
[90] M. Duchen,et al. Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity , 2003, The Journal of Neuroscience.
[91] U. Hanisch,et al. Microglia as a source and target of cytokines , 2002, Glia.
[92] S. Finkbeiner,et al. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. , 1990, Science.
[93] S. Kirischuk,et al. Na+/Ca2+ exchanger modulates kainate‐triggered Ca2+ signaling in Bergmann glial cells in situ , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[94] C. Weigert. Beiträge zur Kenntnis der normalen menschlichen Neuroglia : Festschrift zum fünfzigjährigen Jubiläum des ärztlichen Vereins zu Frankfurt a. M., 3. November 1895 , 1895 .
[95] P. Heinrich,et al. Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes , 1989, FEBS letters.
[96] M. Lenhossék. Der feinere Bau des Nervensystems im Lichte neuester Forschungen , 1893 .
[97] M. Hüll,et al. Microglial expression of prostaglandin EP3 receptor in excitotoxic lesions in the rat striatum , 2004, Neurochemistry International.
[98] Holger Heine,et al. Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease , 2007, Cellular Physiology and Biochemistry.
[99] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[100] V. Gundersen,et al. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate , 2004, Nature Neuroscience.
[101] P. Carmeliet,et al. Protective Role of Reactive Astrocytes in Brain Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[102] R. North,et al. NMDA Receptors Mediate Neuron-to-Glia Signaling in Mouse Cortical Astrocytes , 2006, The Journal of Neuroscience.
[103] J. Levine,et al. Localization of a neurectoderm-associated cell surface antigen in the developing and adult rat. , 1986, Brain research.
[104] Ling Li,et al. Role of toll-like receptor signalling in Abeta uptake and clearance. , 2006, Brain : a journal of neurology.
[105] C. Iadecola,et al. Glial regulation of the cerebral microvasculature , 2007, Nature Neuroscience.
[106] J. Meldolesi,et al. Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.
[107] Nicholas Lange,et al. D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.
[108] J. Wegiel,et al. Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease , 2004, Neurobiology of Aging.
[109] Y. Chong,et al. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: possible involvement of multiple signal transduction and β-catenin/T-cell factor , 2004, Journal of Neuroimmunology.
[110] Jullie W Pan,et al. Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysis. , 2004, Journal of neurosurgery.
[111] P. Agostinho,et al. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades , 2008, Neuroscience.
[112] H. Neumann,et al. Neuronal ‘On’ and ‘Off’ signals control microglia , 2007, Trends in Neurosciences.
[113] P. Eikelenboom,et al. Inflammatory mechanisms in Alzheimer's disease. , 1994, Trends in pharmacological sciences.
[114] J. Kril,et al. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. , 2004, Brain : a journal of neurology.
[115] K. Nave,et al. Mechanisms of Disease: inherited demyelinating neuropathies—from basic to clinical research , 2007, Nature Clinical Practice Neurology.
[116] E. Newman,et al. Control of extracellular potassium levels by retinal glial cell K+ siphoning. , 1984, Science.
[117] Joachim W. Deitmer,et al. Calcium signalling in glial cells , 1998 .
[118] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[119] S. Oliet,et al. Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory , 2006, Cell.
[120] P. Grammas,et al. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.
[121] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[122] W. Snider,et al. Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration , 2000, The Journal of Neuroscience.
[123] F. Rossi,et al. Synergistic Induction of Nitric Oxide by β-Amyloid and Cytokines in Astrocytes , 1996 .
[124] B. Bergamasco,et al. Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients , 2006, Neurological Sciences.
[125] M. Schultzberg,et al. β-amyloid protein structure determines the nature of cytokine release from rat microglia , 2007, Journal of Molecular Neuroscience.
[126] Thomas Klockgether,et al. Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice , 2005 .
[127] S. Ferroni,et al. Cascading Glia Reactions: a Common Pathomechanism and Its Differentiated Control by Cyclic Nucleotide Signaling , 2000, Annals of the New York Academy of Sciences.
[128] A. Verkhratsky. Patching the glia reveals the functional organisation of the brain , 2006, Pflügers Archiv.
[129] U. Dirnagl,et al. Role of glial cells in cerebral ischemia , 2005, Glia.
[130] Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.
[131] P. Somogyi,et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.
[132] F. Pfrieger,et al. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats , 2009, Journal of neurochemistry.
[133] L. Mucke,et al. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.
[134] C. Brosnan,et al. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.
[135] T. Takano,et al. An astrocytic basis of epilepsy , 2005, Nature Medicine.
[136] D. McTigue,et al. The life, death, and replacement of oligodendrocytes in the adult CNS , 2008, Journal of neurochemistry.
[137] M. Ilyas Kamboh,et al. A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism , 1995, Nature Genetics.
[138] A. Volterra,et al. Focal degeneration of astrocytes in amyotrophic lateral sclerosis , 2008, Cell Death and Differentiation.
[139] A. Volterra,et al. Astrocytic dysfunction: Insights on the role in neurodegeneration , 2009, Brain Research Bulletin.
[140] B. Schürmann,et al. The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice , 2005, The Journal of Neuroscience.
[141] P. Gebicke-haerter,et al. Expression and regulation of cyclooxygenase-2 in rat microglia. , 1997, European journal of biochemistry.
[142] Michael M. Halassa,et al. Synaptic Islands Defined by the Territory of a Single Astrocyte , 2007, The Journal of Neuroscience.
[143] Nathalie Rouach,et al. Astroglial Metabolic Networks Sustain Hippocampal Synaptic Transmission , 2008, Science.
[144] Stuart A. Lipton,et al. Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.
[145] A. Butt. Structure and function of oligodendrocytes , 2004 .
[146] F. Kirchhoff,et al. Glia: the fulcrum of brain diseases , 2007, Cell Death and Differentiation.
[147] A. Aloisi,et al. Cognitive function in young and adult IL (interleukin)-6 deficient mice , 2004, Behavioural Brain Research.
[148] Andriezen Wl,et al. The Neuroglia Elements in the Human Brain , 1893 .
[149] A. Hazell. Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy , 2009, Neurochemistry International.
[150] L. Barbeito,et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis , 2004, Brain Research Reviews.
[151] P. Ince,et al. Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis , 2000 .
[152] J. Trojanowski,et al. Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration , 2005, The Journal of Neuroscience.
[153] T Suenaga,et al. Alterations in glia and axons in the brains of Binswanger's disease patients. , 1997, Stroke.
[154] M. C. Angulo,et al. Target cell-specific modulation of neuronal activity by astrocytes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[155] M. Botto. C1q Knock-Out Mice for the Study of Complement Deficiency in Autoimmune Disease , 1999, Experimental and Clinical Immunogenetics.
[156] C. Théry,et al. Interleukin 1 and tumor necrosis factor-alpha stimulate the production of colony-stimulating factor 1 by murine astrocytes. , 1992, Journal of neurochemistry.
[157] P. Eikelenboom,et al. Neuroinflammatory perspectives on the two faces of Alzheimer’s disease , 2004, Journal of Neural Transmission.
[158] David Boltz,et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration , 2009, Proceedings of the National Academy of Sciences.
[159] A. Troncoso,et al. Regional differences in astrocyte activation in HIV-associated dementia. , 2006, Medicina.
[160] Sung-Chun Tang,et al. Toll-like receptors in neurodegeneration , 2009, Brain Research Reviews.
[161] Thomas Klockgether,et al. Nonsteroidal Anti-Inflammatory Drugs and Peroxisome Proliferator-Activated Receptor-γ Agonists Modulate Immunostimulated Processing of Amyloid Precursor Protein through Regulation of β-Secretase , 2003, The Journal of Neuroscience.
[162] H. Hampel,et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro , 2001, Glia.
[163] G. Landreth,et al. Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α , 2001, Neurochemistry International.
[164] W. Gan,et al. ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.
[165] M. Rattray,et al. NG2 cells differentiate into astrocytes in cerebellar slices , 2009, Molecular and Cellular Neuroscience.
[166] Michal Schwartz,et al. The bright side of the glial scar in CNS repair , 2009, Nature Reviews Neuroscience.
[167] H. Kettenmann,et al. Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.
[168] M. Landt,et al. Analysis of Cerebrospinal Fluid Glial Fibrillary Acidic Protein after Seizures in Children , 2003, Epilepsia.
[169] W. Stallcup. The NG2 proteoglycan: Past insights and future prospects , 2002, Journal of neurocytology.
[170] Ana Gadea,et al. Glial transporters for glutamate, glycine and GABA I. Glutamate transporters , 2001, Journal of neuroscience research.
[171] D. Feinstein,et al. Expression and function of inducible nitric oxide synthase in neurons , 2001, Journal of Neuroimmunology.
[172] Khaleel Bhaukaurally,et al. Glutamate exocytosis from astrocytes controls synaptic strength , 2007, Nature Neuroscience.
[173] Frank W Pfrieger,et al. New views on synapse—glia interactions , 1996, Current Opinion in Neurobiology.
[174] L. Fetler,et al. Brain Under Surveillance: The Microglia Patrol , 2005, Science.
[175] A. Alzheimer,et al. Histologische und histopathologische Arbeiten über die Grosshirnrinde : mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskrankheiten , 1904 .
[176] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[177] Geoffrey Burnstock,et al. Purinergic signalling in the nervous system: an overview , 2009, Trends in Neurosciences.
[178] M. Mena,et al. Glia conditioned medium protects fetal rat midbrain neurones in culture from L‐DOPA toxicity , 1996, Neuroreport.
[179] G. Burnstock,et al. Purinoceptors on Neuroglia , 2009, Molecular Neurobiology.
[180] M. Nilsson,et al. Astrocyte activation and reactive gliosis , 2005, Glia.
[181] B. Barres,et al. Thrombospondins 1 and 2 are Necessary for Synaptic Plasticity and Functional Recovery after Stroke , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[182] Cathryn L. Kubera,et al. Astrocytic Purinergic Signaling Coordinates Synaptic Networks , 2005, Science.
[183] J. Wiltfang,et al. Amyloid beta peptide 1–40 enhances the action of Toll‐like receptor‐2 and ‐4 agonists but antagonizes Toll‐like receptor‐9‐induced inflammation in primary mouse microglial cell cultures , 2005, Journal of neurochemistry.
[184] G. Pasinetti,et al. A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[185] E. Hirsch,et al. Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease , 2002, Journal of neurochemistry.
[186] D. Attwell,et al. The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia , 2006, The Journal of physiology.
[187] D. Attwell,et al. Glutamate release in severe brain ischaemia is mainly by reversed uptake , 2000, Nature.
[188] A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. , 2000 .
[189] T. Wyss-Coray,et al. Adult mouse astrocytes degrade amyloid-β in vitro and in situ , 2003, Nature Medicine.
[190] P. Caroni,et al. Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease , 2002, The Journal of Neuroscience.
[191] G. Kroemer,et al. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia , 2005, Cell Death and Differentiation.
[192] A. Verkhratsky. Calcium ions and integration in neural circuits , 2006, Acta physiologica.
[193] A. Hazell,et al. Loss of astrocytic glutamate transporters in Wernicke encephalopathy , 2010, Glia.
[194] Rhona Mirsky,et al. Negative regulation of myelination: Relevance for development, injury, and demyelinating disease , 2008, Glia.
[195] F. Kirchhoff,et al. Glutamate‐mediated neuronal–glial transmission , 2007, Journal of anatomy.
[196] J. Kril,et al. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies , 2004, Acta Neuropathologica.
[197] S. Goldman,et al. Astrocytic complexity distinguishes the human brain , 2006, Trends in Neurosciences.
[198] S. Lockett,et al. Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide* , 2006, Journal of Biological Chemistry.
[199] M. Beal,et al. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis , 2005, Experimental Neurology.
[200] R. Bruzzone,et al. Connexins and information transfer through glia. , 1999, Advances in experimental medicine and biology.
[201] R. Swanson. Astrocyte Neurotransmitter Uptake , 2004 .
[202] P. Gasque,et al. Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.
[203] N. Hamilton,et al. Synantocytes: the fifth element , 2005, Journal of anatomy.
[204] Mark Ellisman,et al. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development , 2004, International Journal of Developmental Neuroscience.
[205] F. Helmchen,et al. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.
[206] S. Duan,et al. P2X7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes , 2003, The Journal of Neuroscience.
[207] D. Attwell,et al. Modulation of extracellular glutamate concentration in rat brain slices by cystine‐glutamate exchange , 1999, The Journal of physiology.
[208] M. Nedergaard,et al. Connexin 43 Hemichannels Are Permeable to ATP , 2008, The Journal of Neuroscience.
[209] T. Klockgether,et al. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[210] Tullio Pozzan,et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes , 1998, Nature.
[211] K. Moore,et al. Journal of Neuroinflammation BioMed Central , 2004 .
[212] T. Hartmann,et al. TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPs , 1999 .
[213] A. Carè,et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.
[214] R. North,et al. P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes , 2008, The Journal of Neuroscience.
[215] L R Caplan,et al. Binswanger's disease. , 1993, Advances in neurology.
[216] A. Contestabile,et al. Neuroprotection of microglial conditioned medium on 6‐hydroxydopamine‐induced neuronal death: role of transforming growth factor beta‐2 , 2009, Journal of neurochemistry.
[217] J. Dichgans,et al. Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo , 2000, Journal of neurochemistry.
[218] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[219] A. Verkhratsky,et al. Glial Neurobiology: A Textbook , 2007 .
[220] J. Rothstein,et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS , 2002, Annals of neurology.
[221] S. Wesselingh,et al. Correlation between neurological progression and astrocyte apoptosis in HIV‐associated dementia , 2001, Annals of neurology.
[222] Miguel Maravall,et al. The Barrel Cortex as a Model to Study Dynamic Neuroglial Interaction , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[223] Y. Suh,et al. C‐terminal fragment of amyloid precursor protein induces astrocytosis , 2001, Journal of neurochemistry.
[224] G. Pasinetti,et al. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. , 1999, The American journal of pathology.
[225] H. Engler,et al. Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET , 2007, Journal of the Neurological Sciences.
[226] P. Mcgeer,et al. Brain inflammation in Alzheimer disease and the therapeutic implications. , 1999, Current pharmaceutical design.
[227] Kevin Eggan,et al. Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.
[228] T. Montine,et al. Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced Aβ Phagocytosis yet Lack Aβ-Activated Neurotoxicity , 2005 .
[229] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[230] Maiken Nedergaard,et al. New roles for astrocytes (stars at last) , 2003, Trends in Neurosciences.
[231] G. Carmignoto,et al. Astrocyte control of synaptic transmission and neurovascular coupling. , 2006, Physiological reviews.
[232] Julia W. Chang,et al. Interleukin‐1β Induces Prostaglandin G/H Synthase‐2 (Cyclooxygenase‐2) in Primary Murine Astrocyte Cultures , 1996, Journal of neurochemistry.
[233] K. Talbot,et al. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.
[234] J. Parkinson. An Essay on the Shaking Palsy , 2002 .
[235] Scott Ferrell,et al. Message and protein-level elevation of tumor necrosis factor α (TNFα) and TNFα-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis , 2003, Neurobiology of Disease.
[236] K. Frei,et al. Production of macrophage colony-stimulating factor by astrocytes and brain macrophages , 1992, Journal of Neuroimmunology.
[237] Y. Suh,et al. α‐Synuclein induces migration of BV‐2 microglial cells by up‐regulation of CD44 and MT1‐MMP , 2009, Journal of neurochemistry.
[238] B. Hyman,et al. Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.
[239] S. Wilks. Lectures on Diseases of the Nervous System , 1885, Buffalo Medical and Surgical Journal.
[240] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[241] C. Steinhäuser,et al. Ion channels in glial cells , 2000, Brain Research Reviews.
[242] T. Takadera,et al. Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons , 2004, Neurochemistry International.
[243] Milos Pekny,et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury , 2006, Proceedings of the National Academy of Sciences.
[244] R. North,et al. Vesicular release of ATP at central synapses , 2006, Pflügers Archiv.
[245] S. Goldman,et al. New roles for astrocytes: Redefining the functional architecture of the brain , 2003, Trends in Neurosciences.
[246] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[247] A Verkhratsky,et al. Neuronismo y reticulismo: neuronal–glial circuits unify the reticular and neuronal theories of brain organization , 2009, Acta physiologica.
[248] P. Mcgeer,et al. Marked increase in cyclooxygenase-2 in ALS spinal cord , 2001, Neurology.
[249] C. Giaume,et al. Astrocyte calcium waves: What they are and what they do , 2006, Glia.
[250] J. Dichgans,et al. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation , 2003 .
[251] M. C. Angulo,et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation , 2003, Nature Neuroscience.
[252] Christian Steinhäuser,et al. Astrocyte dysfunction in neurological disorders: a molecular perspective , 2006, Nature Reviews Neuroscience.
[253] R. Mrak,et al. Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[254] A. Verkhratsky,et al. Glial calcium: homeostasis and signaling function. , 1998, Physiological reviews.
[255] F. Di Virgilio,et al. Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression1 , 2009, The Journal of Immunology.
[256] Hynek Wichterle,et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons , 2007, Nature Neuroscience.
[257] J. Julien,et al. Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2002, Neurobiology of Disease.
[258] Y. Chong. Effect of a carboxy-terminal fragment of the Alzheimer's amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells. , 1997, Life sciences.
[259] M. Duchen,et al. β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.
[260] L. Mucke,et al. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine , 1996, Brain Research.
[261] E. Scarpini,et al. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35] , 1999, Journal of Neuroimmunology.
[262] D. Standaert,et al. Targeted Overexpression of Human &agr;-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease , 2008, Journal of neuropathology and experimental neurology.
[263] L. Lue,et al. Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[264] C. Wernicke,et al. Lehrbuch der Gehirnkrankheiten für Aerzte und Studirende , 1881 .
[265] Richard D. Kim,et al. Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice* , 2004, Journal of Biological Chemistry.
[266] A. Lees. The Parkinson chimera , 2009, Neurology.
[267] A. Pérez-Samartín,et al. Excitotoxic damage to white matter , 2007, Journal of anatomy.
[268] S. Miller,et al. Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease1 , 2006, The Journal of Immunology.
[269] F. Jessen,et al. A genetic variation of the inflammatory cytokine interleukin‐6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease , 1999, Annals of neurology.
[270] R. Go,et al. The role of TNF and its receptors in Alzheimer’s disease , 2001, Neurobiology of Aging.
[271] L. Hersh,et al. Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.
[272] G. Perea,et al. Tripartite synapses: astrocytes process and control synaptic information , 2009, Trends in Neurosciences.
[273] K. Talbot,et al. Motor neurone disease , 2002, Postgraduate medical journal.
[274] B. Volpe,et al. APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomy , 2002, Glia.
[275] T. Montine,et al. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity , 2005, Glia.
[276] F. Kirchhoff,et al. NMDA Receptors in Glia , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[277] J. Silver,et al. Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease , 1998, Experimental Neurology.
[278] G. Kollias,et al. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.
[279] K. Hensley,et al. Temporal patterns of cytokine and apoptosis‐related gene expression in spinal cords of the G93A‐SOD1 mouse model of amyotrophic lateral sclerosis , 2002 .
[280] T. Komori,et al. Tau‐positive dial Inclusions in Progressive Supranuclear Palsy, Corticobasal Degeneration and Pick's Disease , 1999, Brain pathology.
[281] F. Haiss,et al. Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance , 2008, The Journal of Neuroscience.
[282] B T Hyman,et al. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. , 1999, Journal of neurovirology.
[283] R. Orkand,et al. Modification of potassium movement through the retina of the drone (Apis mellifera male) by glial uptake. , 1983, The Journal of physiology.
[284] P. Haydon,et al. Astrocytic glutamate targets NMDA receptors , 2007, The Journal of physiology.
[285] C. Giaume,et al. Gap Junction-Mediated Astrocytic Networks in the Mouse Barrel Cortex , 2008, The Journal of Neuroscience.
[286] D. Rampe,et al. Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. , 2001, Journal of neurochemistry.
[287] Todd A Fiacco,et al. What Is the Role of Astrocyte Calcium in Neurophysiology? , 2008, Neuron.
[288] Betty Y. S. Kim,et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.
[289] C. Weigert,et al. Beiträge zur Kenntnis der normalen menschlichen Neuroglia , 1896 .
[290] S. Mckercher,et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.
[291] F. Pfrieger,et al. Roles of glial cells in synapse development , 2009, Cellular and Molecular Life Sciences.
[292] P. Mcgeer,et al. Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[293] G. Sobue,et al. Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[294] L. McCullough,et al. Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia , 2004, The Journal of Neuroscience.
[295] P. Magistretti,et al. Activity‐dependent regulation of energy metabolism by astrocytes: An update , 2007, Glia.
[296] D. Holtzman,et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.
[297] H. Sontheimer,et al. Spontaneous intracellular calcium oscillations in cortical astrocytes from a patient with intractable childhood epilepsy (Rasmussen's Encephalitis) , 1997, Glia.
[298] P. Mcgeer,et al. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs , 1999, Brain Research.
[299] V. Nguyen,et al. Immunological aspects of microglia: relevance to Alzheimer's disease , 2001, Neurochemistry International.
[300] B. Hyman,et al. Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice , 2009, Science.
[301] H. Arias,et al. The role of inflammation in Alzheimer's disease. , 2005, The international journal of biochemistry & cell biology.
[302] W. Gong,et al. CpG‐containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1–42 peptide by up‐regulating the expression of the G‐protein‐coupled receptor mFPR2 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[303] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[304] J. Trojanowski,et al. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. , 2004, The American journal of pathology.
[305] Helmut Kettenmann,et al. Calcium signalling in glial cells , 1996, Trends in Neurosciences.